Table 1 of
Hu, Mol Vis 2007;
13:1379-1389.Table 1 of
Hu, Mol Vis 2007;
13:1379-1389.
Table 1. Patient characteristics and examination findings
The table demonstrates the gender, age, and treatment protocols assigned for each patient, the results of tear function tests, ocular surface vital stainings, conjunctival inflammatory cell densities (as determined by confocal microscopy), and conjunctival injection grades assessed by slit lamp microscopy. Note the comparatively higher conjunctival injection grades, lower BUT values, higher vital staining scores and higher inflammatory cell numbers in patients not using CsA. RE: right eye; LE: left eye; TS: topical steroid; TAA: topical antiallergic; CsA: topical cyclosporine; BUT: tear film break-up time; FS: fluorescein score; RB: Rose Bengal score; ICD: inflammatory cell density; G: grade.
Conjunctival Confocal
Age injection Schirmer BUT FS RB ICD
Number Patient Gender (years) Treatment grade (mm) (s) (pts) (pts) (cells/mm2)
------ ------- ------ ------- ---------- ------------- -------- --- ----- ----- -----------
1 O.Y. RE M 11 TS+TAA+CsA Severe (G3) 15 6 9 6 1781
LE 27 6 9 6 1781
2 O.K. RE M 13 TS+TAA+CsA Moderate (G2) 12 6 9 9 1143
LE 35 6 9 9 1140
3 K.M. RE M 27 TS+TAA+CsA Moderate (G2) 5 2 9 4 1281
LE 5 3 6 3 250
4 K.J. RE M 25 TS+TAA+CsA Moderate (G2) 2 3 9 4 556
LE 2 3 5 4 431
5 M.S. RE M 20 TS+TAA+CsA Moderate (G2) 7 6 9 6 NA
LE 9 5 0 0 264
6 F.M. RE M 23 TS+TAA+CsA Moderate (G2) 12 2 0 0 437
LE 12 3 1 1 875
7 M.T. RE M 27 TS+TAA+CsA Moderate (G2) 6 3 9 9 543
LE 9 2 9 9 150
8 Y.T. RE M 17 TS+TAA+CsA Moderate (G2) 13 5 2 0 750
LE 25 5 3 0 587
9 Y.K. RE M 33 TS+TAA Severe (G3) 24 8 9 0 868
LE 20 8 9 0 650
10 S.A. RE M 22 TS+TAA Severe (G3) 16 2 9 9 2058
LE 16 3 9 9 2218
11 S.T. RE M 13 TS+TAA Severe (G3) 7 0 9 9 1450
LE 13 1 9 9 1446
12 M.T. RE M 27 TS+TAA Severe (G3) 6 3 9 9 1600
LE 9 2 9 9 1296
13 Y.J. RE M 37 TS+TAA Severe (G3) 22 1 9 9 1460
LE 22 1 9 9 1436
14 K.T. RE M 9 TS+TAA Severe (G3) 25 0 9 9 1800
LE 25 0 9 9 1096
|